Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE 16:00:02 2026-10-13 EDT			5-day change	1st Jan Change
51.66 ^USD	-0.08%		+2.14%	+39.77%

10-08	Disney Holds Talks With Paramount, Universal on Using Imax Rival	MT
10-08	Disney Holds Talks With Paramount, Universal on Using Imax Rival	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

86be5846199.KnHi0blBCyFHhvWJwJI0vQBC1uyCabwWyUu3Q7DmgNA.a1yo6doFQ34my6_cjMUA2zl1utrpRPUuqiTbKom2tLxcKIyQzg9cUwHfzQ~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

10-08	B. Riley Raises Price Target on IMAX to $64 From $61, Keeps Buy Rating	MT
09-24	Morgan Stanley Initiates IMAX at Overweight With $63 Price Target	MT
08-24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
07-24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
07-24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
07-24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
07-24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
07-16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
07-16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
07-10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
05-18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
05-04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
05-01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
04-23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
04-17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
02-27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
02-26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
02-26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
12-15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
12-08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
12-08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
12-08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
12-08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
11-25	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
25-10-24	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT

More recommendations

Other Entertainment Production

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IMAX CORPORATION					+9.77%
	LIVE NATION ENTERTAINMENT, INC.					+19.05%
	UNIVERSAL MUSIC GROUP N.V.					+44.8%
	ROKU, INC.					+6.23%
	WARNER MUSIC GROUP CORP.					+31.98%
	TKO GROUP HOLDINGS, INC.					+33.54%
	BOLLORÉ SE					+13.48%
	PARAMOUNT SKYDANCE CORPORATION					+2.86%
	MADISON SQUARE GARDEN SPORTS CORP.					+19.17%
	TOHO CO., LTD.					+13.04%
	Average					+19.39%
	Weighted average by Cap.					+22.48%